{"id":"https://openalex.org/W4362567702","doi":"https://doi.org/10.1158/1541-7786.c.6539617.v1","title":"Data from Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity","display_name":"Data from Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362567702","doi":"https://doi.org/10.1158/1541-7786.c.6539617.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.c.6539617.v1","doi":"https://doi.org/10.1158/1541-7786.c.6539617.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6539617.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1541-7786.c.6539617.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042132774","display_name":"Jen\u2010Wei Huang","orcid":"https://orcid.org/0000-0001-8345-1656","observed_orcids":["https://orcid.org/0000-0001-8345-1656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jen-Wei Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087622468","display_name":"Yemin Wang","orcid":"https://orcid.org/0000-0002-2970-9510","observed_orcids":["https://orcid.org/0000-0002-2970-9510"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yemin Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052870601","display_name":"Kiranjit K. Dhillon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kiranjit K. Dhillon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003373949","display_name":"Philamer C. Calses","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philamer Calses","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110902","display_name":"Emily Villegas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily Villegas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018499917","display_name":"Patrick S. Mitchell","orcid":"https://orcid.org/0000-0001-8375-9060","observed_orcids":["https://orcid.org/0000-0001-8375-9060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick S. Mitchell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079940700","display_name":"Muneesh Tewari","orcid":"https://orcid.org/0000-0002-7781-3152","observed_orcids":["https://orcid.org/0000-0002-7781-3152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muneesh Tewari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112265164","display_name":"Christopher J. Kemp","orcid":"https://orcid.org/0000-0001-7238-8452","observed_orcids":["https://orcid.org/0000-0001-7238-8452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher J. Kemp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5036540850","display_name":"Toshiyasu Taniguchi","orcid":"https://orcid.org/0000-0002-7746-3658","observed_orcids":["https://orcid.org/0000-0002-7746-3658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshiyasu Taniguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.7109000086784363,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.7109000086784363,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.2705000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10515","display_name":"Cancer-related molecular mechanisms research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microrna","display_name":"microRNA","score":0.8610000014305115},{"id":"https://openalex.org/keywords/mir-103","display_name":"miR-103","score":0.9890000224113464},{"id":"https://openalex.org/keywords/mir-107","display_name":"miR-107","score":1.0},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rad51d","display_name":"RAD51D","score":0.996999979019165},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.9869999885559082},{"id":"https://openalex.org/keywords/homology-directed-repair","display_name":"homology-directed repair","score":0.8659999966621399},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.878000020980835},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7459999918937683},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.8960000276565552},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.6570000052452087},{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.8870000243186951},{"id":"https://openalex.org/keywords/ionizing-radiation","display_name":"ionizing radiation","score":0.8899999856948853},{"id":"https://openalex.org/keywords/microrna-mimics","display_name":"miRNA mimics","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.979896068572998},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.7408865690231323},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.7012102007865906},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.679790735244751},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.6716811060905457},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.629165530204773},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6201108694076538},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5934551358222961},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5255674123764038},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.5126644968986511},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.4517948627471924},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.39621418714523315},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.370799720287323},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3594561815261841},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3343822658061981},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.298244833946228},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.278286874294281},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.14644962549209595},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1541-7786.c.6539617.v1","doi":"https://doi.org/10.1158/1541-7786.c.6539617.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6539617.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.c.6539617.v1","doi":"https://doi.org/10.1158/1541-7786.c.6539617.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6539617.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2171039798","https://openalex.org/W4392680185","https://openalex.org/W2106671241","https://openalex.org/W2007138966","https://openalex.org/W2466575983","https://openalex.org/W2330343052","https://openalex.org/W2899007688","https://openalex.org/W2620768197","https://openalex.org/W2897588930","https://openalex.org/W2928369260"],"abstract_inverted_index":{"Abstract":[0],"Homologous":[1],"recombination":[2,19,84],"mediates":[3],"error-free":[4],"repair":[5,152],"of":[6,42,77,82,94,125,143,190,243],"DNA":[7,48,233],"double-strand":[8],"breaks":[9],"(DSB).":[10],"RAD51":[11,108,144,178],"is":[12,25,85,182],"an":[13],"essential":[14],"protein":[15],"for":[16,184,227],"catalyzing":[17],"homologous":[18,83],"and":[20,34,52,60,130,148,153,162,172,176,179,207,213,229,245],"its":[21,32],"recruitment":[22],"to":[23,46,55,101,113,156,218,247],"DSBs":[24],"mediated":[26],"by":[27,192],"many":[28],"factors":[29,44],"including":[30,160],"RAD51,":[31],"paralogs,":[33],"breast/ovarian":[35],"cancer":[36,244],"susceptibility":[37],"gene":[38,72],"products":[39],"BRCA1/2.":[40],"Deregulation":[41],"these":[43,202],"leads":[45],"impaired":[47],"repair,":[49,235],"genomic":[50,211],"instability,":[51],"cellular":[53],"sensitivity":[54],"chemotherapeutics":[56],"such":[57],"as":[58,132],"cisplatin":[59,161],"PARP":[61,164],"inhibitors.":[62],"microRNAs":[63],"(miRNA)":[64],"are":[65,134],"short,":[66],"noncoding":[67],"RNAs":[68],"that":[69,105,169,205],"posttranscriptionally":[70],"regulate":[71,177],"expression;":[73],"however,":[74],"the":[75,80,126,141,241],"contribution":[76],"miRNAs":[78,104],"in":[79,111,116,137,196,231,240],"regulation":[81,189],"not":[86],"well":[87],"understood.":[88],"To":[89],"address":[90],"this,":[91],"a":[92,163,225],"library":[93],"human":[95,117],"miRNA":[96],"mimics":[97],"was":[98,194],"systematically":[99],"screened":[100],"pinpoint":[102],"several":[103,197],"significantly":[106],"reduce":[107],"foci":[109,145],"formation":[110],"response":[112,246],"ionizing":[114],"radiation":[115],"osteosarcoma":[118],"cells.":[119],"Subsequent":[120],"study":[121],"focused":[122],"on":[123],"two":[124],"strongest":[127],"candidates,":[128],"miR-103":[129,147,171,206,228],"miR-107,":[131],"they":[133],"frequently":[135],"deregulated":[136],"cancer.":[138],"Consistent":[139],"with":[140],"inhibition":[142],"formation,":[146],"miR-107":[149,173,208],"reduced":[150],"homology-directed":[151],"sensitized":[154],"cells":[155],"various":[157],"DNA-damaging":[158],"agents,":[159],"inhibitor.":[165],"Mechanistic":[166],"analyses":[167],"revealed":[168],"both":[170],"directly":[174],"target":[175],"RAD51D,":[180],"which":[181],"critical":[183],"miR-103/107\u2013mediated":[185],"chemosensitization.":[186],"Furthermore,":[187],"endogenous":[188],"RAD51D":[191],"miR-103/107":[193],"observed":[195],"tumor":[198],"subtypes.":[199],"Taken":[200],"together,":[201],"data":[203],"show":[204],"overexpression":[209],"promotes":[210],"instability":[212],"may":[214],"be":[215],"used":[216],"therapeutically":[217],"chemosensitize":[219],"tumors.":[220],"Implications:":[221],"These":[222],"findings":[223],"demonstrate":[224],"role":[226],"-107":[230],"regulating":[232],"damage":[234],"thereby":[236],"identifying":[237],"new":[238],"players":[239],"progression":[242],"chemotherapy.":[248],"Mol":[249],"Cancer":[250],"Res;":[251],"11(12);":[252],"1564\u201373.":[253],"\u00a92013":[254],"AACR.":[255]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-06T00:00:00"}